Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 120,354 | 188,888 | 222,080 | 71,548 | 68,156 |
| Marketable Securities | 256,439 | 222,136 | 224,865 | 158,281 | 185,091 |
| Receivables | 13,102 | N/A | N/A | N/A | N/A |
| TOTAL | $392,287 | $420,056 | $448,396 | $238,252 | $262,555 |
| Non-Current Assets | |||||
| PPE Net | 256 | 266 | 278 | 158 | 166 |
| Investments And Advances | 12,125 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1,769 | 1,900 | 983 | 1,093 | 338 |
| TOTAL | $14,150 | $2,166 | $1,261 | $1,251 | $504 |
| Total Assets | $406,437 | $422,222 | $449,657 | $239,503 | $263,059 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,212 | 3,568 | N/A | 9,489 | 7,030 |
| Accounts payable and accrued liabilities | 6,438 | 8,231 | 5,669 | 5,122 | 3,624 |
| Accrued Expenses | 16,974 | 18,421 | 14,465 | 13,732 | 11,724 |
| Other current liabilities | N/A | N/A | 187 | N/A | N/A |
| TOTAL | $30,925 | $30,551 | $20,683 | $28,712 | $24,292 |
| Non-Current Liabilities | |||||
| Long Term Debt | 12,994 | 16,479 | 19,895 | 10,989 | 13,323 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 1,517 |
| Other Non-Current Liabilities | 570 | 643 | 711 | 798 | 22 |
| TOTAL | $13,572 | $17,122 | $20,606 | $11,787 | $24,204 |
| Total Liabilities | $44,497 | $47,673 | $41,289 | $40,499 | $48,496 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,565 | 56,232 | 55,012 | 49,392 | 48,628 |
| Common Shares | 6 | 6 | 6 | 5 | 5 |
| Retained earnings | -618,443 | -580,871 | -543,702 | -639,900 | -619,261 |
| Other shareholders' equity | -1,335 | -640 | 45 | 11 | 17 |
| TOTAL | $361,940 | $374,549 | $408,368 | $199,004 | $214,563 |
| Total Liabilities And Equity | $406,437 | $422,222 | $449,657 | $239,503 | $263,059 |